Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-09 4:39 pm Purchase | 2025-07-01 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 1,276,595 7.400% | 1,094,280 (+600.21%) | Filing History |
| 2025-07-03 2:07 pm Purchase | 2025-06-27 | 13G | NEKTAR THERAPEUTICS NKTR | Integrated Core Strategies (US) LLC | 932,863 5.400% | 932,863 (New Position) | Filing History |
| 2025-05-15 3:35 pm Sale | 2025-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | Samlyn Capital, LLC | 0 0.000% | -644,470 (Position Closed) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 835,200 6.700% | -229,423 (-21.55%) | Filing History |
| 2025-02-14 1:49 pm Purchase | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Samlyn Capital, LLC | 644,470 5.200% | 644,470 (New Position) | Filing History |
| 2025-02-14 12:08 pm Sale | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Eventide Asset Management, LLC | 443,333 3.610% | -183,334 (-29.26%) | Filing History |
| 2025-02-14 08:43 am Sale | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital, LP | 131,733 1.070% | -929,777 (-87.59%) | Filing History |
| 2024-11-14 12:17 pm Purchase | 2024-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Eventide Asset Management, LLC | 626,667 5.110% | 626,667 (New Position) | Filing History |
| 2024-11-14 09:18 am Sale | 2024-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital, LP | 1,061,510 8.650% | -165,157 (-13.46%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 1,064,623 8.700% | 0 (Unchanged) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 1,064,623 8.700% | 491,002 (+85.60%) | Filing History |
| 2024-03-15 4:18 pm Purchase | 2024-03-06 | 13G | NEKTAR THERAPEUTICS NKTR | TCG Crossover GP II, LLC | 1,336,423 9.900% | 1,336,423 (New Position) | Filing History |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | RA Capital Management, L.P. | 0 0.000% | -1,246,667 (Position Closed) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Citadel Advisors LLC | 375,675 3.000% | -272,975 (-42.08%) | Filing History |
| 2024-02-14 08:50 am Purchase | 2023-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital, LP | 1,226,667 9.650% | 406,518 (+49.57%) | Filing History |
| 2024-02-13 5:09 pm Sale | 2023-12-29 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 802,858 6.310% | -888 (-0.11%) | Filing History |
| 2023-08-17 4:30 pm Purchase | 2023-08-07 | 13G | NEKTAR THERAPEUTICS NKTR | RA Capital Management, L.P. | 1,246,667 9.800% | 1,246,667 (New Position) | Filing History |
| 2023-07-10 2:09 pm Sale | 2023-07-10 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 369,029 2.900% | -2,119,469 (-85.17%) | Filing History |
| 2023-07-10 10:41 am Sale | 2023-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 803,746 6.370% | -733,972 (-47.73%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 573,621 4.500% | -646,424 (-52.98%) | Filing History |